tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Vyome Holdings presents results from VT-1908 preclinical studies

Vyome Holdings (HIND) presented results from its preclinical studies investigating VT-1908 for treating uveitis at the recent Annual Meeting of the American Society for Pharmacology and Experimental Therapeutics. In a preclinical model of anterior uveitis, the most common form of uveitis, the twice-daily application of VT-1908 eyedrops significantly reduced the uveitis score. The efficacy of VT-1908 was found to be similar to a clinically used steroid.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1